Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?
Liver inflammation, injury, and hepatic cell death are caused by external agents (viruses, bacteria, drugs, alcohol, etc.) along with the genetic susceptibility of an individual. Persistent activation of the fibrogenic response in cells leads to liver fibrosis which in turn progresses to cirrhosis a...
Saved in:
Main Author: | Zahid Hussain |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2025-01-01
|
Series: | Exploration of Digestive Diseases |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100563/100563.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer Cell‐Derived Exosomal miR‐500a‐3p Modulates Hepatic Stellate Cell Activation and the Immunosuppressive Microenvironment
by: Yu Zhang, et al.
Published: (2025-01-01) -
Bone marrow mesenchymal stem cell-originated exosomes suppress activation of hepatic stellate cells through the miR-144-3p/SLC7A11 axis
by: Yanqin Hao, et al.
Published: (2024-09-01) -
AdipoRon mitigates liver fibrosis by suppressing serine/glycine biosynthesis through ATF4-dependent glutaminolysis
by: Xiangting Zhang, et al.
Published: (2025-01-01) -
Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis
by: Aliosha I. Figueroa-Valdés, et al.
Published: (2025-01-01) -
Exosomes derived from liver failure patients’ plasma stimulated mesenchymal stem cells alleviate acute liver failure
by: Zhuoran Wang, et al.
Published: (2025-02-01)